Neurocrine (NBIX) Reports Notable Safety Results from NBI-98854 Phase II
Go back to Neurocrine (NBIX) Reports Notable Safety Results from NBI-98854 Phase II| Neurocrine Biosciences, Inc. (NASDAQ: NBIX) | Delayed: 154.03 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $154.03 | 52 Week High | $58.46 | |||
| Open | $154.03 | 52 Week Low | $31.25 | |||
| Day High | $154.03 | P/E | N/A | |||
| Day Low | $154.03 | EPS | $-0.69 | |||
| Volume | 1,014 | |||||
